For MTC patients, the doubling times of both calcitonin and CEA are efficient tools for assessing tumor progression.
No takes yet. Share an insight, caveat, or question.
Giraudet et al. (2008) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: